SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits
Medical technology firm says it made disclosure after it was certain kits could be commercialised
Add BT as a preferred source
Singapore
BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.
In an exchange filing on Thursday, the firm also said it only received approval for the product to be manufactured and marketed under its own brand some time later.
TRENDING NOW
Why China is tightening controls on overseas stock trading
Xi Jinping has just rewritten the rules of US-China rivalry
‘Even a CEO’s job can be replaced by AI’: DBS CEO Tan Su Shan bets big on agentic AI
‘Whole deck of cards just toppled’: FoodXervices’ Nichol Ng on how a 92-year-old family business unravelled – and what’s next
